Table 3 The results of meta-regression analyses
From: Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis
Model | Covariates | Meta-regression β coefficient (SE) | 95% CI of β coefficient | p value |
|---|---|---|---|---|
Pooled RR for included studies (Figure 2) | Age at HL diagnosis Latency since HL treatment | −0.105 (0.015) −0.010 (0.031) | −0.137 to −0.072 −0.075 to 0.055 | <0.0001 0.747 |
RR versus follow-up intervals (Figure 6) | Age at HL diagnosis | −0.036 (0.010) | −0.057 to −0.015 | 0.001 |
RR versus therapy modality (Figure 7): RT vs. RT + C vs. C | Age at HL diagnosis Latency since HL treatment | −0.099 (0.027) −0.095 (0.073) | −0.157 to −0.041 −0.251 to 0.061 | 0.003 0.212 |